Anticancer effects of PEP06 (TB01) in combination with Trifluridine/Tipiracil (TAS-102) in a xenograft model of human colorectal cancer
Abstract Background Colorectal cancer (CRC) is the third most common cancer globally, with advanced stages presenting significant treatment challenges. Recently years, drug combination therapy has become a promising strategy for cancer treatment. Objective To evaluate the therapeutic efficacy of the...
Saved in:
Main Authors: | Ruohong Lin, Jiaxing Cheng, Jinlong Zhao, Liang Zhou, Jian Li, Xinchun Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2024-12-01
|
Series: | Journal of Cancer Research and Clinical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1007/s00432-024-05984-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trifluridine/tipiracil regimen in combination with bevacizumab for metastatic colorectal cancer in the third line: an expert opinion
by: Carmine Pinto, et al.
Published: (2025-01-01) -
Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trialResearch in context
by: Niels A.D. Guchelaar, et al.
Published: (2025-02-01) -
Hubungan antara Beban Tas dengan Risiko Skoliosis pada Siswa Kelas 4-6 Sekolah Dasar
by: Komang Trisna Handayani, et al.
Published: (2024-06-01) -
Kültür Devriminden “Büyük Terör” e: Çön Taş’taki Siyasi Katliam
by: Hikmet ÖKSÜZ, et al.
Published: (2020-12-01) -
OUTBREAK OF TOBAMOVIRUSES AND POTEXVIRUSES ASSOCIATED WITH DISEASE EPIDEMICS IN TOMATO PRODUCTION AREA OF IRAQ
by: Hasaneen K. Obaid, et al.
Published: (2025-01-01)